Singulair (Montelukast) Lawsuit 2026: FDA Boxed Warning, Neuropsychiatric Injuries, and Where Litigation Stands
The FDA's 2020 boxed warning linked montelukast to suicidal ideation, depression, and aggression — especially in children. Here's what that means for litigation, who may have a claim, and what the MCL 637 docket looks like in 2026.
Singulair Montelukast FDABoxedWarning